GlassScriptPhysician profile
Mildred D Geeter
NPI 1811018641
$3,116.67
in general payments reported to CMS, 2019-2025
18 companies · $871 in 2025
The $871 reported for 2025 was more than what 95% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $475 · 2022: $366 · 2023: $824 · 2024: $580 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $508.98 | 2022-2025 | Airsupra, Breztri, Fasenra |
| Abbvie INC. | $417.55 | 2021-2023 | |
| Novo Nordisk INC | $372.16 | 2021-2025 | Ozempic |
| Boston Scientific Corporation | $262.82 | 2023-2025 | Watchman Access System, Watchman Flx |
| Sumitomo Pharma America, INC. | $213.50 | 2024 | Gemtesa, Myfembree |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $124.17 | 2021-2022 | |
| Noah Medical Corporation | $123.68 | 2025 | Galaxy |
| Mylan Specialty L.P. | $123.51 | 2022 | |
| Lundbeck LLC | $118.04 | 2023 | Vyepti |
| Genentech USA, INC. | $113.29 | 2021 | |
| Akcea Therapeutics, INC. | $112.11 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $103.40 | 2025 | |
| Amgen INC. | $103.40 | 2025 | Repatha |
| Pharmacosmos Therapeutics INC. | $101.01 | 2023 | Monoferric |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $74.82 | 2023 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $62.90 | 2023 | |
| Axsome Therapeutics, INC. | $56.34 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mildred Geeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.